Evidence for mitochondrial K(ATP) channels as effectors of human myocardial preconditioning

Cardiovascular Research

Volumn 45, Issue 4, 2000, Pages 934-940

  Ghosh, Sudip ^a   Standen, Nicholas B ^a   Galiñanes, Manuel ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Ion channels; K ATP channel; Mitochondria; Preconditioning

Indexed keywords

5 HYDROXYDECANOIC ACID; CLAMIKALANT; CREATINE KINASE; DIAZOXIDE; GLIBENCLAMIDE; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; HEART MITOCHONDRION; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RIGHT ATRIUM; HEART SURGERY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; CELL MEMBRANE; DECANOIC ACIDS; DIAZOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; HEART; HUMANS; HYDROXY ACIDS; HYPOGLYCEMIC AGENTS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA; PINACIDIL; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RANDOM ALLOCATION; SARCOLEMMA; SULFONAMIDES; THIOUREA;

EID: 0033962709     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00407-1     Document Type: Article

References (34)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
2. Schott R.J., Rohmann S., Braun E.R., Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res. 66:1990;1133-1142.
3. Miller D.L., Van Winckle D.M. Ischemic preconditioning limits infarct size following regional ischemia-reperfusion in in situ mouse hearts. Cardiovasc Res. 42:1999;680-684.
4. Goto M., Liu Y., Yang X.-M., et al. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 77:1995;611-621.
5. Yellon D.M., Alkhulaifi A.M., Pugsley W.B. Preconditioning the human myocardium. Lancet. 342:1993;276-277.
6. Carrol R., Yellon D.M. Myocardial adaptation to ischemia - the preconditioning phenomenon. Int J Cardiol. 68:1999;S93-S101.
7. Grover G. Pharmacology of ATP-sensitive potassium channel (K-ATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol. 75:1997;309-315.
8. Gross G.J., Auchampach J.A. Blockade of ATP-dependant potassium channels prevents myocardial preconditioning. Circ Res. 70:1992;223-233.
9. Schulz R., Rose J., Heusch G. Involvement of activation of ATP-dependant potassium channels in ischemic preconditioning in swine. Am J Physiol. 267:1994;H1341-1352.
10. Armstrong S., Liu G., Downey J., Ganote C. Potassium channels and preconditioning of isolated rabbit cardiomyocytes. Effects of glyburide and pinacidil. J Mol Cell Cardiol. 27:1995;1765-1774.
11. ATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol. 26:1995;145-152.
12. + blocker dofetilide. Am J Physiol. 40:1996;H1207-H1214.
13. Garlid K., Paucek P., Yarov-Yarovoy V., et al. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: a possible mechanism of cardioprotection. Circ Res. 81:1997;1072-1082.
14. Liu Y., Sato T., O'Rourke B., Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 97:1998;2463-2469.
15. + channel blocker. Circulation. 90:1994;700-705.
16. + channel. Circ Res. 77:1995;1020-1035.
17. Ghosh S, Standen NB, Galiñanes M. Preconditioning the human myocardium by simulated ischemia. Studies on the early and delayed protection. Cardiovasc Res:1999;in press.
18. ATP channel by glyburide and 5-hydroxydecanoate. J Biol Chem. 273:1998;13578-13582.
19. McCullough J.R., Mormandin D.E., Conder M.L., et al. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ Res. 69:1991;949-958.
20. + channels by protein kinase C. Circ Res. 83:1998;110-114.
21. Gogelein H., Hartung J., Engelbert H., Scholkens B. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive of the ATP-sensitive potassium channel. Part I: effects on cardiomyocytes, coronary flow and pancreatic B-cells. J Pharmacol Exp Ther. 286:1998;1453-1464.
22. ATP blocker HMR 1883 in rabbits. Br J Pharmacol. 24:1998;SS25P.
23. Auchampach J., Grover G., Gross G. Blockade of ischemic preconditioning in dogs by novel ATP-dependent potassium channel antagonist sodium-5-hydroxydecanoate. Cardiovasc Res. 26:1992;1054-1062.
24. Carr C.S., Grover G.J., Pugsley W.B., Yellon D.M. Comparison of the protective effects of a highly selective ATP-sensitive potassium channel opener and ischemic preconditioning in isolated human atrial muscle. Cardiovasc Drugs Ther. 11:1997;473-477.
25. Kelpzig H., Kobert G., Matter C., et al. Sulfonyl ureas and ischemic preconditioning. Euro Heart J. 20:1999;439-446.
26. + channel opening drugs. Am J Physiol. 269:1995;H525-H545.
27. + channels. News Physiol Sci. 13:1998;131-137.
28. Suzuki M., Kotake K., Fujikura K., et al. Kir 6.1: A possible subunit of ATP-sensitive K+ channels in mitochondria. Biochem Biophys Res Comm. 241:1997;693-697.
29. Gross G.J., Fryer R.M. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ Res. 84:1999;973-979.
30. ATP channel as a receptor for potassium channel openers. J Biol Chem. 27:1996;8796-8799.
31. Cleveland J.C. Jr., Wollmering M.M., Meldrum D.R., et al. Ischemic preconditioning in human and rat ventricle. Am J Physiol. 271:1996;H1786-H1794.
32. Heidbuchel H., Vereecke J., Carmeliet E. Three different potassium channels in human atrium: contribution to the basal potassium conductance. Circ Res. 66:1990;1277-1286.
33. + channels by 5-hydroxydecanoate in guinea pig ventricular myocytes. J Pharmacol Exp Ther. 260:1992;1702-1708.
34. ATP channels. Mol Pharmacol. 55:1999;1000-1005.